Back to Research News Research News and Information

2275 Swallow Hill Road - Building 2500 - Pittsburgh, PA 15220
(412) 429-0673 Fax: (412) 279-1367

Press Release


Pittsburgh, PA - December 10, 1996 - Biocontrol Technology, Inc. (NASDAQ:BICO) announced today that it recently submitted a protocol to the Food and Drug Administration (FDA) for the upcoming in-home study requested by the FDA as part of the Company's ongoing 510(k) submission process for its Diasensor 1000TM noninvasive glucose sensor for diabetics.

BICO hopes to hear soon from the FDA that the study can proceed. The Company is ready to begin shortly after this approval has been obtained.

Biocontrol Technology, Inc. has its corporate offices in Pittsburgh, PA and is involved in the development and manufacture of biomedical devices and environmental products.


  Back to Research News Return to the Top of This Page

Last Updated: Thursday February 27, 2014 19:28:21
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.